Pilianidis, G., G. . Papanastasiou, P. . Tikoudi, A. . Themistocleous, G. . Farmakis, and K. . Dolianitis. “Can Euglycemic Diabetic Ketoacidosis Caused by SGLT2 Inhibitors Be Avoided in COVID-19 and Other Acute Infections?”. European Journal of Case Reports in Internal Medicine, vol. 11, no. 3, Feb. 2024, doi:10.12890/2024_004282.